🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Current and future progress to overcoming targeted drug resistance for #GastrointestinalCancers fal.cn/3d0L1 #ASCOEdBook #GICSM #GI21

Grateful for grant support from Cholangiocarcinoma Foundation to create a biological blueprint for the metastatic spread of cholangiocarcinoma. Understanding why and how cancer spreads is the first step to refining our clinical strategy in advanced disease. Stanford Cancer Institute cholangiocarcinoma.org/professionals/…

Excited to talk about career development in drug development!

#cfDNA from rapid autopsies can capture #clonal and #subclonal alterations of #metastatic #tumours, and may reveal more drivers than single tissue biopsies #CancerResearch Cancer at Nature Portfolio go.nature.com/2QX6d4h

As the field of #precisiononcology shifts to a new generation of molecular targets, SCI members Christopher Chen & Jim Ford believe iteration on drug development strategies will help achieve the next generation of clinical breakthroughs. bit.ly/3ItUSPG

Having a wonderful time at the annual Stanford Oncology/Hematology/BMT-CT retreat at Asilomar. Great to see our amazing first year fellows onstage and enjoying fantastic talks including by Chris Chen, MD and Thomas Yang Sun Two wonderful days ahead Shruti Patel, MD Steven Artandi, MD, PhD